IHS FormWeb
Approved Formulary
Search by name
Search by class
Browse alphabetically
Select...
NUM
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
High Alert
Restricted Medications
Renal Adjustment Policy
Therapeutic Interchange Policy
Hazard.Drug Handling(USP 800)
Hazardous Waste
Chemotherapy
IV to PO Conversion Policy
Black Box Warnings
Look-Alike/Sound-Alike
REMS
Staff Telephone Numbers
Webpage Links
Add Formweb to your mobile device
Android
iOS
Home
QuickStart
Admin
IHS FormWeb
Approved Formulary
Search by name
Additional search options
Search by class
Browse alphabetically
Select...
NUM
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
High Alert
Restricted Medications
Renal Adjustment Policy
Therapeutic Interchange Policy
Hazard.Drug Handling(USP 800)
Hazardous Waste
Chemotherapy
IV to PO Conversion Policy
Black Box Warnings
Look-Alike/Sound-Alike
REMS
Staff Telephone Numbers
Webpage Links
Search results for:
pamidronate
pamidronate
Restricted Medications
Outpatient: only for osteoporosis
Brand names:
Aredia
Form
Strength
SOLUTION, INTRAVENOUS
3 mg/mL; 9 mg/mL
Display
Bone Resorption Inhibitors
Class:
922400
Medication comments:
Per policy, use of these medications is restricted as noted below:
View all
generic (Brand)
Restrictions
pamidronate (Aredia)
Inpatient: no restrictions
Outpatient: only for osteoporosis
USP <800> Hazardous Drug Assessment of Risk (AOR)
View all
Per policy, these drugs are exempt from USP <800> handling requirements under normal circumstances.
The following outlines must be followed.
generic (Brand) Route [Packaging: Manufacturer ⇒ Dispense]
NIOSH Group
pamidronate (Aredia)
IV
[n/a]
Reproductive Risk
Pharmacy:
Receiving /
Storage /
Preparation
Exposure Risk:
low
• Handling/preparation PPE Requirements: Single CX glove,
gown
and
CSTD
.
Do not prepare if pregnant.
• Receiving from Distributor: Standard
• Pharmacy Storage Area: IV area
• Packaging/Reconstitution Location: n/a
• Compounding (Non-Sterile/Sterile) Location:
Ideal:
Positive pressure room
Required:
Med Prep Area with Immediate Use Preparation standards
• Omnicell Load: No
Transport
• Transport (dose is placed inside a plastic sealable bag): Standard
Nursing:
Storage /
Admin.
Exposure Risk:
medium
• Handling/administration PPE Requirements: Single
CX gloves
,
gown
• Storage of Finished dose in Nursing Area/Procedural Area: Patient Med Drawer
• Signage on Patient Door Required: No
• Manipulation of Dosage Form: n/a
• Special Manipulation for Administration: Do not handle while pregnant
Disposal /
Spills
• Disposal of Drug Waste: Full-
blue bin
, trace/packaging- trash
• Disposol of Used PPE: trash bin (inside plastic bag)
• Spill management: Wear
CX gloves
, items used to clean up spill should be placed in a sealed bag and put in
blue bin
NIOSH Supplemental Information:
Embryo-fetal toxicities at doses below recommended human doses
Reason for exemption of USP<800> Containment Requirements:
Preg Category D. Impervious gloves and
gown
are recommended in MSDS.
Last updated:
Apr. 4, 2024
Hazard.Drug Handling(USP 800)
USP<800> Hazardous Drug / Assessment of Risk
UpToDate
FDA DailyMed Package Insert
MedLinePlus (Patient Information)
MSDS Online
Outpatient: only for osteoporosis
The following outlines must be followed.
Receiving /
Storage /
Preparation
low
Do not prepare if pregnant.
Required: Med Prep Area with Immediate Use Preparation standards
Storage /
Admin.
medium
Spills